Memphasys Ltd (MEM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Memphasys Ltd (MEM) has a cash flow conversion efficiency ratio of -0.306x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.23 Million ≈ $-871.57K USD) by net assets (AU$4.02 Million ≈ $2.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MEM company net worth for the company's overall valuation and market capitalisation.
Memphasys Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Memphasys Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Memphasys Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Memphasys Ltd ranked by their cash flow conversion efficiency. Explore Memphasys Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NEVADA LITHIUM RESOURCES
F:87K
|
-0.009x |
|
Ihlas Ev Aletleri Imalat Sanayi ve Ticaret AS
IS:IHEVA
|
0.009x |
|
Arita Prima Indonesia Tbk
JK:APII
|
0.022x |
|
Intrasense
PA:ALINS
|
0.452x |
|
MODERN COMMERCE SA ZY-10
F:8F4
|
-0.261x |
|
Integritas Viager SA
PA:MLVIE
|
N/A |
|
Swissnet AG
F:81D
|
N/A |
|
FN Factory Outlet Public Company Limited
BK:FN
|
-0.024x |
Annual Cash Flow Conversion Efficiency for Memphasys Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Memphasys Ltd from 2008 to 2025. View latest Memphasys Ltd stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$5.37 Million ≈ $3.80 Million |
AU$-2.41 Million ≈ $-1.71 Million |
-0.449x | +5.01% |
| 2024-06-30 | AU$6.84 Million ≈ $4.84 Million |
AU$-3.23 Million ≈ $-2.29 Million |
-0.473x | -148.09% |
| 2023-06-30 | AU$7.38 Million ≈ $5.23 Million |
AU$-1.41 Million ≈ $-995.31K |
-0.190x | -567.12% |
| 2022-06-30 | AU$7.65 Million ≈ $5.41 Million |
AU$311.82K ≈ $220.63K |
0.041x | +685.09% |
| 2021-06-30 | AU$8.61 Million ≈ $6.09 Million |
AU$44.71K ≈ $31.63K |
0.005x | -57.84% |
| 2020-06-30 | AU$9.76 Million ≈ $6.90 Million |
AU$120.19K ≈ $85.05K |
0.012x | +110.57% |
| 2019-06-30 | AU$6.07 Million ≈ $4.30 Million |
AU$-707.47K ≈ $-500.58K |
-0.117x | +47.11% |
| 2018-06-30 | AU$3.35 Million ≈ $2.37 Million |
AU$-738.42K ≈ $-522.48K |
-0.220x | -107.21% |
| 2017-06-30 | AU$-402.24K ≈ $-284.61K |
AU$-1.23 Million ≈ $-869.31K |
3.054x | +455.22% |
| 2016-06-30 | AU$1.48 Million ≈ $1.05 Million |
AU$-1.27 Million ≈ $-899.02K |
-0.860x | +73.50% |
| 2015-06-30 | AU$746.59K ≈ $528.26K |
AU$-2.42 Million ≈ $-1.71 Million |
-3.244x | -442.08% |
| 2014-06-30 | AU$-992.85K ≈ $-702.50K |
AU$-941.64K ≈ $-666.27K |
0.948x | +771.03% |
| 2013-06-30 | AU$6.99 Million ≈ $4.95 Million |
AU$-987.97K ≈ $-699.05K |
-0.141x | +1.56% |
| 2012-06-30 | AU$4.56 Million ≈ $3.23 Million |
AU$-655.09K ≈ $-463.52K |
-0.144x | +40.80% |
| 2011-06-30 | AU$7.00 Million ≈ $4.95 Million |
AU$-1.70 Million ≈ $-1.20 Million |
-0.243x | -18.49% |
| 2010-06-30 | AU$12.84 Million ≈ $9.09 Million |
AU$-2.63 Million ≈ $-1.86 Million |
-0.205x | +79.64% |
| 2009-06-30 | AU$-398.47K ≈ $-281.94K |
AU$400.62K ≈ $283.46K |
-1.005x | +72.30% |
| 2008-06-30 | AU$1.10 Million ≈ $779.28K |
AU$-4.00 Million ≈ $-2.83 Million |
-3.630x | -- |
About Memphasys Ltd
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port… Read more